What we are studying
You have been asked to take part in this study because you have a type of head and neck cancer which is called Squamous Cell Carcinoma of the Head and Neck (SCCHN). Your cancer has either returned or has spread to other parts of your body (either recurrent or metastatic). This study is being carried out to see if experimental anti-cancer medicines called MEDI4736 and MEDI4736 + tremelimumab are effective in treating the type of cancer that you have compared to standard, approved treatment.
A stipend will be provided to assist with parking and travel related to study visits.